Purpose
To provide access to mRNA technology to Development Country Vaccine Manufacturers to enable them to develop and manufacture mRNA vaccines for the low-and middle- income countries.
Grantee
Division
Global Health
Date
NOVEMBER 2023
Region served
GLOBAL
Committed amount
$5,244,775
Grant topic
Vaccine Development
Duration (months)
28
Grantee location
Cape Town, Western Cape, South Africa
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.